skip to the main content

Total Anti-Infliximab

Detecting the presence of total (free and bound) antibodies against Infliximab in patients being treated with Infliximab for chronic autoimmune and inflammatory conditions.

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Total Anti-Infliximab can detect the presence of anti-drug antibodies against Infliximab, requiring only a small amount of human serum or plasma, and delivering results in 22 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

  • CE

Available Instruments

About Using Reagent

  • Sample Types

    Serum, Plasma
  • Reaction Time

    22 mins
  • Detection Range

    8-250 AU/mL
  • Intended Use

    Semi-quantitative determination of free and bound antibodies against Infliximab in human serum/plasma

In Your Medical Field

AFIAS Total Anti-Infliximab test detects the total (free and bound) antibodies against Infliximab with a small amount of human serum or plasma. It provides valuable insights into patients’ response to the treatment of Infliximab.